News
Oyster Point Pharma has taken two big steps recently to advance development of its OC-01 nasal-spray candidate to treat dry eye disease: the closing of…
Read More
Collaborative care models – optometrists and ophthalmologists working together on patient care – are emerging as a way to reduce some of the strain caused…
Read More
Most transformations are predictable: A caterpillar will turn into a butterfly; a cell will be genetically altered should extraneous DNA enter its membrane. Predictable would…
Read More
The OIS Index of ophthalmic stocks gained 7.9% in May, following a 12.2% gain in April, extending the rebound from the mid-March lows. Over the…
Read More
Before Tetra Bio-Pharma‘s recent announcement of US Food and Drug Administration Orphan Drug Designation for its ophthalmic clinical program, ophthalmology was one of the few…
Read More
The glaucoma space has been dominated by a host of products designed to lower intraocular pressure (IOP) – minimally invasive glaucoma surgery (MIGS) devices and…
Read More
Now that it has closed on its $63 billion acquisition of Allergan, AbbVie has significantly expanded its revenue base, which could help cushion the blow…
Read More
Eyenuk Inc.’s first product, the EyeArt AI eye screening system, is an artificial intelligence (AI) technology for autonomous detection of diabetic retinopathy that’s been tested…
Read More
The stage of ophthalmic innovation has hosted a multitude of new acts, people going from established companies to start-ups and vice versa and back again,…
Read More
Developing a delivery system to replace eye drops has been an important unmet need in ophthalmology. Drops are difficult or impossible for some patients to…
Read More
The turmoil in the stock market over the past month or so has sent leading healthcare indices reeling, casting a cloud over the financing that…
Read More
Dry eye disease and allergic conjunctivitis are two flourishing markets within ophthalmology. The dry eye market is expected to climb to $5.1 billion by the…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")